Exogenous glucagon-like peptide 1: a potentially novel therapy for the management of hyperglycaemia in the critically ill

Lignende værker

• The effect of exogenous glucagon-like peptide-1 on the glycaemic response to small intestinal nutrient in the critically ill: a randomised double-blind placebo-controlled cross over study
  af: Deane, Adam M, et al.
  Udgivet: (2009)
• Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
  af: Chapman, M, et al.
  Udgivet: (2011)
• The Effect of Exogenous Glucose-Dependent Insulinotropic Polypeptide in Combination With Glucagon-Like Peptide-1 on Glycemia in the Critically Ill
  af: Lee, Michael Y., et al.
  Udgivet: (2013)
• Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes
  af: Deane, Adam M, et al.
  Udgivet: (2011)
• The therapeutic potential of a venomous lizard: the use of glucagon-like peptide-1 analogues in the critically ill
  af: Deane, Adam M, et al.
  Udgivet: (2010)